Table 3. Echocardiographic parameters of testicular cancer patients before and after chemotherapeutic treatment.
|
Before
|
After
|
||||
|---|---|---|---|---|---|
| n a | Median (range) | n | Median (range) | P-valueb | |
| Systolic parameters | |||||
| WMSI | 33 | 1.00 (1.00–1.23) | 28 | 1.00 (0.81–1.44) | 0.273 |
| Structural dimensions | |||||
| Septum (mm) | 42 | 10 (6–12) | 41 | 10 (7–14) | 0.427 |
| Posterior wall (mm) | 41 | 10 (8–12) | 41 | 9 (7–11) | 0.309 |
| LVEDD (mm) | 42 | 50 (41–57) | 41 | 50 (41–55) | 0.861 |
| LVESD (mm) | 41 | 32 (18–42) | 41 | 32 (21–41) | 0.741 |
| LA parasternal (mm) | 42 | 35 (25–42) | 41 | 35 (25–46) | 0.198 |
| LA length (mm) | 40 | 57 (44–69) | 41 | 58 (46–69) | 0.764 |
| LA transverse (mm) | 24 | 38 (29–45) | 31 | 39 (29–52) | 0.267 |
| Heartbeat (bpm) | 34 | 70 (48–105) | 31 | 66 (48–105) | 0.235 |
| Valve dysfunction (n) | 42 | 3 (7.1%) | 42 | 5 (11.9%) | 0.457 |
| Diastolic parameters | |||||
| Peak E velocity (cm s–1) | 42 | 0.76 (0.58–1.06) | 41 | 0.82 (0.58–1.31) | 0.302 |
| Peak A velocity (cm s–1) | 42 | 0.59 (0.31–0.99) | 41 | 0.61 (0.35–1.38) | 0.097 |
| E/A-ratio | 42 | 1.38 (0.73–2.84) | 41 | 1.35 (0.53–2.30) | 0.259 |
| TVI Et (cm s–1)c | 22 | 12.0 (7–19) | 25 | 10.0 (7–17) | 0.002 |
| E/E′c | 22 | 6.2 (3.8–12.4) | 25 | 7.6 (4.1–13.1) | 0.002 |
| Blood pressure d | |||||
| Systolic (mm Hg) | 42 | 129 (107–154) | 38 | 123 (106–153) | 0.011 |
| Diastolic (mm Hg) | 42 | 74 (58–99) | 38 | 70 (54–106) | 0.018 |
a
Number of patients in which the respective parameters were available.
b
Wilcoxon signed-rank test.
c
19 paired observations available.
d
24 h ambulatory blood pressure recordings.